Scott Tarriff, President and CEO at EAGLE PHARMACEUTICALS, INC. (EGRX), sold 19,339 shares at $65.50 ($1.2M) on 2015-11-02, disclosed to the SEC on 2015-11-03.
Scheduled sale ($1.2M) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $64.07 | 11,713 | $750K | 60.0% |
| 2 | $65.50 | 7,626 | $500K | 40.0% |
| Total | $64.63 avg | 19,339 | $1.2M | 100% |
| Filing → |
| EGRX | SELL | 2023-05-18 | $300K | — | Filing → |
| EGRX | SELL | 2023-05-15 | $1.2M | — | Filing → |
| EGRX | SELL | 2019-04-03 | $2.5M | — | Filing → |